non glp 1 weight loss meds Decoding GLP-1 Medications *Based on a 2024 survey of pharmacists who recommend branded vitamins and supplements Potential GLP-1 Alternative Promises Weight
Description
More research must be conducted to understand the true mechanisms of action
The goal is not simply to be lighter
In November 2023, a new GLP-1, called tirzepatide (Zepbound, Mounjaro), was approved for weight loss and obesity management
That is a goal worth pursuing, and one that is medically achievable with the right support
Keith, you can do so here
Lilly and Novo Nordisk also presented findings at the diabetes conference
